2017
DOI: 10.1007/164_2016_122
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches

Abstract: Inflammatory bowel diseases, most commonly categorized as Crohn's disease and ulcerative colitis, are immune mediated chronic inflammatory disorders of the gastrointestinal tract. The etiopathogenesis is multifactorial with different environmental, genetic, immune mediated, and gut microbial factors playing important role. The current goals of therapy are to improve clinical symptoms, control inflammation, prevent complications, and improve quality of life. Different therapeutic agents, with their indications,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
65
0
5

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(71 citation statements)
references
References 104 publications
0
65
0
5
Order By: Relevance
“…In a recent meta-analysis, steroid use, low albumin level, preoperative surgical history, and preoperative abscess were retained as risk factors for adverse surgical outcome [56]. Besides steroids and thiopurines, biologics such as anti-TNF provide new treatment options for disease control [57]. However, the influence of these drugs on postoperative outcome is matter of debate.…”
Section: Discussionmentioning
confidence: 99%
“…In a recent meta-analysis, steroid use, low albumin level, preoperative surgical history, and preoperative abscess were retained as risk factors for adverse surgical outcome [56]. Besides steroids and thiopurines, biologics such as anti-TNF provide new treatment options for disease control [57]. However, the influence of these drugs on postoperative outcome is matter of debate.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism of action of 5-Amino salicylates includes the stimulation of class of nuclear receptors which mainly include cell proliferation and inflammation. It helps in decreasing the production of chemoattractant leukotriene and slows down the cellular release of interleukin-1 and 2 [24]. 5-ASA Common side effect like flatulence, nausea, abdominal pain, diarrhea, headache, dyspepsia, nasopharyngitis [25], [26].…”
Section: Aminosalicylatesmentioning
confidence: 99%
“…Cellular Physiology and Biochemistry therapeutic goals are to achieve clinical remission and improve quality of life [38]. Although environmental factors provide an enormous contribution to the development of IBD, the pathogenesis of IBD remains unclear, thereby limiting the discovery of effective therapeutic targets for IBD.…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 99%